Search research articles
Contact Us
Filters
Showing results (11-20 of 142) with videos related to
Page
of 15
Sort By:
The American Journal of Psychiatry
|
May 2, 2017
Antidepressant Pharmacogenetics
Ajeet B Singh, Chad A Bousman
Pharmacogenetics and Genomics
|
November 3, 2025
Pharmacogenetic testing coverage by Canadian insurance providers
Ruby Brubaker-Plitt, Chad A Bousman
PCN Reports : Psychiatry and Clinical Neurosciences
|
June 13, 2024
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic
Abdullah Al Maruf, Chad A Bousman
Pharmacogenetics and Genomics
|
March 9, 2018
Reply to Searcy and colleagues
Chad A Bousman, Philip Jaksa, Christos Pantelis
Pharmacogenetics and Genomics
|
February 15, 2024
Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis
Courtney Lenz, Ankita Narang, Chad A Bousman
The Nursing Clinics of North America
|
May 9, 2025
The Use of Pharmacogenomics in Mental Health
Trina Walker, Crystal Dodson, Chad A Bousman
Pharmacogenetics and Genomics
|
August 5, 2017
Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting
Chad A Bousman, Philip Jaksa, Christos Pantelis
Journal of Clinical Psychopharmacology
|
February 2, 2021
Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report
Marlon Danilewitz, Reza Rafizadeh, Chad A Bousman
Genes
|
October 28, 2023
<i>CYP2D6</i> and <i>CYP2C19</i> Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia
Malcolm Forbes, Mal Hopwood, Chad A Bousman
Clinical Pharmacology and Therapeutics
|
April 21, 2019
Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection
Chad A Bousman, Heather Zierhut, Daniel J Müller
Page
of 15
Search research articles
Search
Showing results (11-20 of 142) with videos related to
Sort By:
Page
of 15
The American Journal of Psychiatry
|
May 2, 2017
Antidepressant Pharmacogenetics
Ajeet B Singh, Chad A Bousman
Pharmacogenetics and Genomics
|
November 3, 2025
Pharmacogenetic testing coverage by Canadian insurance providers
Ruby Brubaker-Plitt, Chad A Bousman
PCN Reports : Psychiatry and Clinical Neurosciences
|
June 13, 2024
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic
Abdullah Al Maruf, Chad A Bousman
Pharmacogenetics and Genomics
|
March 9, 2018
Reply to Searcy and colleagues
Chad A Bousman, Philip Jaksa, Christos Pantelis
Pharmacogenetics and Genomics
|
February 15, 2024
Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis
Courtney Lenz, Ankita Narang, Chad A Bousman
The Nursing Clinics of North America
|
May 9, 2025
The Use of Pharmacogenomics in Mental Health
Trina Walker, Crystal Dodson, Chad A Bousman
Pharmacogenetics and Genomics
|
August 5, 2017
Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting
Chad A Bousman, Philip Jaksa, Christos Pantelis
Journal of Clinical Psychopharmacology
|
February 2, 2021
Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report
Marlon Danilewitz, Reza Rafizadeh, Chad A Bousman
Genes
|
October 28, 2023
<i>CYP2D6</i> and <i>CYP2C19</i> Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia
Malcolm Forbes, Mal Hopwood, Chad A Bousman
Clinical Pharmacology and Therapeutics
|
April 21, 2019
Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection
Chad A Bousman, Heather Zierhut, Daniel J Müller
Page
of 15